Kayyem Jon Faiz has filed 31 insider transactions across 2 companies since January 2024.
Most recent transaction: a grant/award of 5443 shares of BIODESIX INC ($BDSX) on January 02, 2026.
Activity breakdown: 11 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | BIODESIX INC | $BDSX | Kayyem Jon Faiz | Not found | A | Restricted Stock Units | 5443 | $0.00 | 5,443.0000 | 7,954,541 | 9999.99% | 0.07% |
| Jan. 2, 2026 | BIODESIX INC | $BDSX | Kayyem Jon Faiz | Not found | A | Stock Options (Right to Buy) | 6354 | $0.00 | 6,354.0000 | 7,954,541 | 9999.99% | 0.08% |
| May 28, 2025 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | A | Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 14,476,000 | 9999.99% | 0.10% |
| May 20, 2025 | BIODESIX INC | $BDSX | Kayyem Jon Faiz | Not found | A | Restricted Stock Units | 68621 | $0.00 | 68,621.0000 | 145,491,569 | 9999.99% | 0.05% |
| May 20, 2025 | BIODESIX INC | $BDSX | Kayyem Jon Faiz | Not found | A | Stock Options (Right to Buy) | 42010 | $0.00 | 42,010.0000 | 145,491,569 | 9999.99% | 0.03% |
| March 27, 2025 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | G | Common Stock | 90000 | $0.00 | 1,059,046.0000 | 14,476,000 | 7.83% | 0.62% |
| Dec. 16, 2024 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | G | Common Stock | 500000 | $0.00 | 1,149,046.0000 | 14,476,000 | 30.32% | 3.45% |
| Dec. 16, 2024 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | G | Common Stock | 250000 | $0.00 | 1,149,046.0000 | 14,476,000 | 27.81% | 1.73% |
| Dec. 16, 2024 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | G | Common Stock | 250000 | $0.00 | 1,149,046.0000 | 14,476,000 | 27.81% | 1.73% |
| Dec. 6, 2024 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | G | Common Stock | 52000 | $0.00 | 1,149,046.0000 | 14,476,000 | 4.33% | 0.36% |
| Nov. 20, 2024 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | P | Common Stock | 18750 | $14.19 | 139,686.0000 | 14,476,000 | 15.50% | 0.13% |
| Nov. 19, 2024 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | P | Common Stock | 34843 | $14.23 | 120,936.0000 | 14,476,000 | 40.47% | 0.24% |
| Nov. 19, 2024 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | P | Common Stock | 34843 | $14.23 | 120,936.0000 | 14,476,000 | 40.47% | 0.24% |
| Nov. 20, 2024 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | P | Common Stock | 18750 | $14.19 | 139,686.0000 | 14,476,000 | 15.50% | 0.13% |
| June 24, 2024 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | G | Common Stock | 10000 | $0.00 | 1,093,860.0000 | 14,475,904 | 0.92% | 0.07% |
| June 24, 2024 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | G | Common Stock | 89050 | $0.00 | 1,093,860.0000 | 14,475,904 | 7.53% | 0.62% |
| June 24, 2024 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | G | Common Stock | 10000 | $0.00 | 1,093,860.0000 | 14,475,904 | 0.92% | 0.07% |
| June 5, 2024 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | P | Common Stock | 49284 | $17.23 | 1,142,145.0000 | 14,475,904 | 4.51% | 0.34% |
| June 5, 2024 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | P | Common Stock | 8265 | $17.89 | 1,150,410.0000 | 14,475,904 | 0.72% | 0.06% |
| June 4, 2024 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | P | Common Stock | 65337 | $17.44 | 1,069,135.0000 | 14,475,904 | 6.51% | 0.45% |
| May 31, 2024 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | P | Common Stock | 70193 | $16.14 | 876,268.0000 | 14,475,904 | 8.71% | 0.48% |
| June 3, 2024 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | P | Common Stock | 46792 | $16.61 | 923,060.0000 | 14,475,904 | 5.34% | 0.32% |
| June 3, 2024 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | P | Common Stock | 80738 | $17.90 | 1,003,798.0000 | 14,475,904 | 8.75% | 0.56% |
| June 4, 2024 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | P | Common Stock | 23726 | $18.24 | 1,092,861.0000 | 14,475,904 | 2.22% | 0.16% |
| May 29, 2024 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | A | Common Stock | 6250 | $0.00 | 818,575.0000 | 49,234,000 | 0.77% | 0.01% |
| May 29, 2024 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | A | Common Stock | 806075 | $0.00 | 818,575.0000 | 49,234,000 | 6448.60% | 1.64% |
| May 29, 2024 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | A | Common Stock | 6250 | $0.00 | 818,575.0000 | 49,234,000 | 0.77% | 0.01% |
| May 30, 2024 | Inhibrx Biosciences, Inc. | $INBX | Kayyem Jon Faiz | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 14,475,904 | 9999.99% | 0.21% |
| May 21, 2024 | BIODESIX INC | $BDSX | Kayyem Jon Faiz | Not found | A | Restricted Stock Units | 46686 | $0.00 | 46,686.0000 | 96,235,883 | 9999.99% | 0.05% |
| May 21, 2024 | BIODESIX INC | $BDSX | Kayyem Jon Faiz | Not found | A | Stock Options (Right to Buy) | 37050 | $0.00 | 37,050.0000 | 96,235,883 | 9999.99% | 0.04% |
| Jan. 1, 2024 | BIODESIX INC | $BDSX | Kayyem Jon Faiz | Not found | A | Restricted Stock Units | 105389 | $0.00 | 134,262.0000 | 96,235,883 | 365.01% | 0.11% |